Skip to main content
. 2010 Sep 2;6(9):e1001093. doi: 10.1371/journal.pgen.1001093

Figure 6. The expression of TXNIP, ARRDC4, and lactic acidosis pathways in human cancers.

Figure 6

(A,C) The tumors in the indicated dataset stratified by the expression of TXNIP (A) and ARRDC4 (B) were used to generate Kaplan-Meier survival curves for linking clinical outcomes with the TXNIP expression levels. (B,D) Scatter plots showing the relationship between the expression of TXNIP (B) or ARRDC4 (D) (Y-axis) and predicted lactic acidosis pathway activities based on the MCF-7 12 hour lactic acidosis gene signatures (X-axis) in the indicated tumor datasets. Each point in the scatter plots represents a single tumor from the indicated breast cancer data sets. The overall correlation (R) and statistical significance/p-value (p) across all samples is shown.